Chemoinformaics analysis of 15-Methylhexadecanoic acid
| Molecular Weight | 270.457 | nRot | 14 |
| Heavy Atom Molecular Weight | 236.185 | nRig | 27 |
| Exact Molecular Weight | 270.256 | nRing | 0 |
| Solubility: LogS | -4.099 | nHRing | 0 |
| Solubility: LogP | 4.596 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 52.665 |
| nHD | 1 | BPOL | 34.977 |
| QED | 0.448 |
| Synth | 3.645 |
| Natural Product Likeliness | 1.674 |
| NR-PPAR-gamma | 0.961 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.082 |
| Pgp-sub | 0.001 |
| HIA | 0.103 |
| CACO-2 | -5.476 |
| MDCK | 0.0000128 |
| BBB | 0.004 |
| PPB | 1.00865 |
| VDSS | 0.348 |
| FU | 0.014572 |
| CYP1A2-inh | 0.855 |
| CYP1A2-sub | 0.664 |
| CYP2c19-inh | 0.293 |
| CYP2c19-sub | 0.085 |
| CYP2c9-inh | 0.835 |
| CYP2c9-sub | 0.704 |
| CYP2d6-inh | 0.425 |
| CYP2d6-sub | 0.164 |
| CYP3a4-inh | 0.337 |
| CYP3a4-sub | 0.246 |
| CL | 3.208 |
| T12 | 0.245 |
| hERG | 0.007 |
| Ames | 0.849 |
| ROA | 0.441 |
| SkinSen | 0.828 |
| Carcinogencity | 0.813 |
| EI | 0.507 |
| Respiratory | 0.151 |
| NR-Aromatase | 0.852 |
| Antiviral | Yes |
| Prediction | 0.621002 |